These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17302188)

  • 61. [Human papillomavirus infection and vaccination].
    He ZH; Kou ZQ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jan; 52(1):106-112. PubMed ID: 29334719
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.
    Goldie SJ; Kohli M; Grima D; Weinstein MC; Wright TC; Bosch FX; Franco E
    J Natl Cancer Inst; 2004 Apr; 96(8):604-15. PubMed ID: 15100338
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human papillomavirus infection: an old disease, a new vaccine.
    Giles M; Garland S
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):180-5. PubMed ID: 16704468
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vaccines for prevention of human papillomavirus infection.
    Foerster V; Murtagh J
    Issues Emerg Health Technol; 2005 Dec; (75):1-4. PubMed ID: 16544439
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human papillomavirus (HPV) vaccines: a Canadian update.
    Foerster V; Murtagh J
    Issues Emerg Health Technol; 2007 Dec; (109):1-8. PubMed ID: 18062141
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Expert consensus on immunological prevention of human papillomavirus-related diseases].
    Vaccine and Immunization Branch, Chinese Preventive Medicine Association
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Aug; 53(8):761-803. PubMed ID: 31378039
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quadrivalent human papillomavirus recombinant vaccine: the first vaccine for cervical cancers.
    Sharma R; Sharma CL
    J Cancer Res Ther; 2007; 3(2):92-5. PubMed ID: 17998730
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human papillomavirus (HPV) and HPV-associated tumour vaccines.
    Bubeník J
    Folia Biol (Praha); 2006; 52(1-2):45-6. PubMed ID: 17007109
    [No Abstract]   [Full Text] [Related]  

  • 69. The HPV vaccine: a content analysis of online news stories.
    Habel MA; Liddon N; Stryker JE
    J Womens Health (Larchmt); 2009 Mar; 18(3):401-7. PubMed ID: 19281323
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine.
    Zhou X; Sun L; Yao X; Li G; Wang Y; Lin Y
    Front Immunol; 2020; 11():1434. PubMed ID: 32754157
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002-June 2005.
    Calloway C; Jorgensen CM; Saraiya M; Tsui J
    J Womens Health (Larchmt); 2006 Sep; 15(7):803-9. PubMed ID: 16999634
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunoprevention of human papillomavirus-associated malignancies.
    Wang JW; Hung CF; Huh WK; Trimble CL; Roden RB
    Cancer Prev Res (Phila); 2015 Feb; 8(2):95-104. PubMed ID: 25488410
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HPV vaccines and cervical cancer.
    Bosch FX
    Ann Oncol; 2008 Jul; 19 Suppl 5():v48-51. PubMed ID: 18611900
    [No Abstract]   [Full Text] [Related]  

  • 74. HPV vaccine for primary prevention of cervical cancer in developing countries: the missing links.
    Sarin R
    J Cancer Res Ther; 2008; 4(3):105-6. PubMed ID: 18923200
    [No Abstract]   [Full Text] [Related]  

  • 75. Emerging human papillomavirus vaccines.
    Ma B; Maraj B; Tran NP; Knoff J; Chen A; Alvarez RD; Hung CF; Wu TC
    Expert Opin Emerg Drugs; 2012 Dec; 17(4):469-92. PubMed ID: 23163511
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel methods to treat and prevent human papillomavirus infection.
    Kendrick JE; Huh WK; Alvarez RD
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):593-600. PubMed ID: 17009939
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting hepatitis B virus and human papillomavirus induced carcinogenesis: novel patented therapeutics.
    Kanwar RK; Singh N; Gurudevan S; Kanwar JR
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):158-74. PubMed ID: 21517743
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunoinformatics applications in the development of therapeutic vaccines against human papillomavirus-related infections and cervical cancer.
    Matos AS; Invenção MDCV; Moura IA; Freitas AC; Batista MVA
    Rev Med Virol; 2023 Sep; 33(5):e2463. PubMed ID: 37291746
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prospects for primary prevention of cervical cancer in developing countries.
    Franceschi S; Clifford G; Plummer M
    Salud Publica Mex; 2003; 45 Suppl 3():S430-6. PubMed ID: 14746036
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tertiary prevention of cervical cancer.
    Divine LM; Huh WK
    Clin Obstet Gynecol; 2014 Jun; 57(2):316-24. PubMed ID: 24633405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.